“The best big pharma stocks offer growth potential thanks to strong pipelines, steady income with dependable dividends, and the opportunity to invest in a business that can make a huge positive impact in the lives of millions of people,” advises the author of today’s article, who proceeds to highlight three such pharma stocks that may be among the best picks…
“It’s a small cap, a billion-dollar company, 100% revenue growth, and it’s small and it’s unknown,” says the author of today’s article of the pharmaceutical marketing company he highlights, which is disrupting the way that drugs are traditionally sold to physicians – and has become a multi-bagger stock in the process. For more on this “under-the-radar pic for investors who…have…
With COVID-19 vaccine stocks Pfizer and Moderna receiving so much attention, the author of today’s article notes that “This leaves a lot of biotech stocks lacking the attention they deserve. While this is bad news for current holders of these stocks, it is an opportunity for new ones.” With this in mind, he proceeds to highlight three “under-loved” biotech stocks…
In making the case for why the biotech featured in today’s article, which is focused on the development of novel antibody-drug conjugate therapeutics for the treatment of cancer, is an attractive investment, the analyst cited points to three primary factors: “the favorable outlook for [its lead candidate], the long-term potential of the biotech’s pipeline and the continuing validation, by partners,…
“Biopharma stocks are risky bets that could fetch disproportionate gains or wipe away one’s entire investment thanks to their vulnerability to catalytic events,” acknowledges the author of today’s article before proceeding to identify nine biotech stocks with key catalysts in the final months of 2020. For these nine stocks and their respective fourth-quarter catalysts and price targets, CLICK HERE.
With their shares having surged by more than 484%, 500% and 275%, respectively, the three stocks highlighted in today’s article are three of the best-performing pharmaceutical stocks over the past year – and despite them having already experienced monster moves higher, it may not be too late to get in on these stocks’ gains. For more on these three pharmaceutical…
Biotech stocks have weathered the coronavirus selloff pretty well on the whole – and today’s article notes that “Several biotechs have delivered solid gains in the midst of the overall stock market plunge.” For three top biotech stock picks that have been beating the market and that still have lots of room to run from here – including one “oddball”…
How can investors – especially retired investors – beat the market without fail? The author of today’s article outlines “a simple step-by-step common sense-based strategy” to do just that, with the following caution: “What I will be presenting may not be what you are expecting, particularly if you have a narrow notion of what beating the market means. In other…
“It’s easier than you think to identify Warren Buffett’s top retirement stock. Don’t overthink it. It’s his own company: Berkshire Hathaway,” declares the author of today’s article, who identifies the “secret” that allows Berkshire to deliver such impressive returns – and which makes it “the single best retirement stock out there today.” For this – and more reasons why Berkshire…
Socially Responsible Investing (SRI) and Environmental, Social and Corporate Governance (ESG) have been gaining popularity as investment approaches, but are ESG/SRI funds good for retirees and soon-to-be-retirees? The author of today’s article believes that “The ensuing debate over SRI and ESG investing is potentially an existential one for retirees and soon-to-be retirees”, given the question as to whether these approaches…